Date & Time of Session - 5/5/26 - from 12:00 - 1:00PM

Overview
Dalbavancin and oritavancin are uncommon antibiotics with potential to help reduce hospital length of stay, while maintaining patient quality of care. Recent studies have shown that dalbavancin is non-inferior to standard of care in complicated Staphylococcus aureus blood stream infections. Is there a potential role for oritavancin as well? How do these agents compare to one another and where do they stack against current standards of therapy such as OPAT and oral antibiotics? 

Objectives
Upon completion of this activity, participants will be able to:
1. Analyze dalbavancin and oritavancin by comparing their mechanisms of action, antimicrobial spectrum, and PK/PD profiles
2. Summarize key landmark clinical trial data and how it affects current clinical decisions
3. Assess the current formulary status of dalbavancin and the potential role of oritavancin at the University of Kentucky

    Target Audience
    Pharmacists, residents, and students

    Special Services
    If you require special assistance to attend this event, please call Megan Russell at (304) 550-0896.

    Speaker:
    Paul Puccio Jr, PharmD
    PGY2 Infectious Disease Pharmacy Resident
    UK College of Pharmacy - Lexington, Kentucky

    Session date: 
    05/05/2026 - 12:00pm EDT to 07/03/2026 - 11:59pm EDT
    Add to calendar: 
    • 1.00 ACPE

      In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

      This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number: JA0000312-0000-25-046-L01-P

    • 1.00 Participation
      UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
    Please login or register to take this course.
    Faculty List: 
    Speaker(s)

    Paul Puccio, PharmD

    has no relevant financial relationships to disclose at this time.